iGan Partners
Venture capitalToronto · Seed–Late Stage · 9 people tracked
Investment thesis
iGan Partners partners with exceptional founders working to commercialize and scale technological advancements in healthcare. The firm positions itself as a provider of 'smart-capital,' pairing investment with active hands-on support and access to a network of industry partners and sector-specific co-investors to help portfolio companies grow. It emphasizes deep domain expertise drawn from the founder's background as engineer, entrepreneur, and investor, and often serves as an early lead investor, remaining involved across subsequent rounds. Its focus spans medical technology and healthcare innovation, supporting scientist-entrepreneurs from early stages through commercialization and clinical adoption.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & curated
What they invest in
from 14 of 28 portfolio companiesHealthtech ×9Medical Devices ×9Digital Health ×8Hardware ×6AI & Machine Learning ×4Biotech ×3SaaS ×2AgTech ×1
HQs:Canada×4United States×3Israel×1
Investments · 28 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 12021 · 12020 · 12014 · 15 dated
eSight makes a wearable, hands-free digital device that uses a camera and image-processing algorithms to enhance sight for people with central vision loss and legal blindness caused by more than 20 eye conditions.
HardwareHealthtechMedical DevicesOttawa
Conrad Lewis(Director)William D. McPhee(Executive Officer, Director)Rob Hilkes(Executive Officer)Tom Houston(Executive Officer)
BoardAbe Schwartz(Director)
Board seatSam Ifergan· per SEC Form D
Co-investorsBoston Harbor Angels
Adenocyte develops LINFU (Low Intensity Non-Focused Ultrasound), a minimally invasive ultrasound technology for routine screening of the pancreas to detect pancreatic dysplasia and early-stage pancreatic cancer.
BiotechHealthtechMedical DevicesHaifa, IL
Mark Rutenberg(Founder & CEO)April Carpenter(Chief Commercial Officer)Robert Harow(Chief Financial Officer)F. Scott Corbett(Chief Medical Officer)Drore Eisen(Medical Research Director)Dan Adam(Chief Technology Officer)
Adracare provides an all-in-one telehealth and practice management software platform for therapists and mental health providers, covering virtual care, patient engagement, and practice administration.
Digital HealthHealthtechMental HealthSaaSToronto, CA
Co-investorsBCF Ventures
Curv Health provides a platform for care providers such as physiotherapists that uses computer vision to remotely track and assess clients' movements, offering client dashboards, secure in-app messaging and video calls, custom exercise program assignment, and automated billing and payouts.
AI & Machine LearningDigital HealthHealthtech
Co-investorsNewfund CapitalBuild Ventures
Manchester, US
Timothy Near(Executive Officer, Director)
Orono, US
Christopher C. Smith(Director)Leroy, III P. McCarty(Executive Officer, Director)
Co-investorsGROOVE CAPITAL
Exact Imaging develops the ExactVu micro-ultrasound platform, a 29 MHz imaging system that lets urologists perform real-time targeted and systematic prostate biopsies within a standard workflow.
HardwareHealthtechMedical DevicesMarkham, CA
Randy AuCoin(President & CEO)William Wortman(Director)Rob Sandler(Executive Officer)Harold Wodlinger(Director)Jerrold Wen(Executive Officer)Diane Lejeune(Director)
Co-investorsLumira VenturesPMVVenture OntarioVesalius Biocapital Partners
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesGenesys CapitalNew Leaf Venture PartnersRBCx
FUJIFILM VisualSonics develops ultra-high to low frequency (71-1MHz) ultrasound imaging systems, including the Vevo LAZR-X20 with photoacoustic imaging, for preclinical and molecular imaging research.
BiotechHardwareMedical Devices
MolecuLight makes an FDA-cleared handheld point-of-care imaging device for wound care that uses fluorescence to detect harmful bacteria, digital measurement to size wounds, and thermal imaging to document skin temperature changes.
Digital HealthHardwareMedical Devices
Co-investorsLIP Ventures BoutiqueHayfin
RetiSpec develops AI-driven retinal imaging technology that uses a simple eye exam to detect biomarkers of Alzheimer's and other neurodegenerative diseases at the point of care.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsVerge HealthTech Fund
RNA Diagnostics is a clinical-stage molecular diagnostics company whose Veridapt DX predictive biomarker platform measures early tumor response to neoadjuvant cancer therapy by monitoring RNA (rRNA) disruption in cells.
BiotechHealthtechMedical Devices
Co-investorsGeorgian Angel Network
Segmed provides structured, de-identified medical imaging data and multimodal datasets from diverse populations to support research in AI and healthcare.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechMedical DevicesSan Francisco, US
Martin Willemink(Co-founder)inJie Wu(Founder)inMarinus Johannes Willemink(Executive Officer, Director)Wojciech Adam Koszek(Executive Officer, Director)Cailin Hardell(Founder)Cailin Kramer(Founder)
Co-investorsBlumberg CapitalExpeditionsMighty CapitalNina CapitalNovaCapitalSouth Quad+1 more
SomaDetect makes sensor hardware and AI-driven analytics that give dairy farmers real-time data on milk quality and herd health.
AgTechAI & Machine LearningHardwareIoT
Bharath Sudarsan(CTO & Founder)Nicholas Clermont(COO & Founder)David Blyth(CEO)
Co-investorsCavallo VenturesThe 51 VenturesThin Air Labs
Portfolio news
latest coverage across their companiesAdenocyte · sharingfromisrael.substack.com · Jun 1, 2026
Flosonics Medical · massdevice.com · Mar 3, 2025
Frequently asked questions
- How many investments has iGan Partners made?
- iGan Partners has 26 tracked investments, including 1 dated in the last 24 months.
- What stage does iGan Partners invest at?
- iGan Partners invests at the Seed, Series A, Growth, Late Stage stages.
- What is iGan Partners's typical check size?
- iGan Partners typically writes checks of $365K – $2.2M.
- What sectors does iGan Partners focus on?
- iGan Partners focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is iGan Partners located?
- iGan Partners is headquartered in Toronto, CA.
- Does iGan Partners lead rounds?
- Yes, iGan Partners leads investment rounds.
- Who does iGan Partners co-invest with?
- iGan Partners most often shares deals with Amplify Capital, Arboretum Ventures, Genesys Capital, among 17 tracked co-investors.
Media · Podcasts & interviews
featuring the teamFounder Friendly - Sam Ifergan, iGan Partners
Beyond Innovation TV · Sam Ifergan
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.